ACT QUETIAPINE
TEVA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ACT QUETIAPINE in Canada?
Yes. ACT QUETIAPINE 300MG has an active shortage reported to Health Canada (last updated July 31, 2026).
Why is ACT QUETIAPINE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will ACT QUETIAPINE be available again?
The estimated resolution date (July 31, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PRO-QUETIAPINE
PRO DOC LIMITEE
VAN-QUETIAPINE
VANC PHARMACEUTICALS INC
RATIO-QUETIAPINE
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
Other Products
JAMP-QUETIAPINE
JAMP PHARMA CORPORATION
SEROQUEL
CHEPLAPHARM ARZNEIMITTEL GMBH
ACCEL-QUETIAPINE
ACCEL PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-07-31
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02316129
Strength
300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
QUETIAPINE
Tier
Unrated
Last Updated
2026-07-31
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
ACT QUETIAPINE has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646